| albuterol 2 MG Oral Tablet albuterol | 4,642 | 91.6%
| T3 | 0% | 1,487 |
| nadolol 20 MG Oral Tablet nadolol | 4,639 | 91.6%
| T2 | 0% | 65,690 |
| nadolol 40 MG Oral Tablet nadolol | 4,639 | 91.6%
| T2 | 0% | 65,690 |
| nadolol 80 MG Oral Tablet nadolol | 4,639 | 91.6%
| T2 | 0% | 65,690 |
| 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML Injection glucose | 4,635 | 91.5%
| T3 | 4.6% | - |
| netarsudil 0.2 MG/ML Ophthalmic Solution [Rhopressa] netarsudil | 4,632 | 91.4%
| T3 | 0.7% | 89,044 |
| metronidazole 7.5 MG/ML Topical Lotion metronidazole | 4,631 | 91.4%
| T3 | 0% | 1,528,785 |
| metformin hydrochloride 500 MG / pioglitazone 15 MG Oral Tablet metformin hydrochloride | 4,628 | 91.3%
| T3 | 0% | 5,918,026 |
| metformin hydrochloride 850 MG / pioglitazone 15 MG Oral Tablet metformin hydrochloride | 4,628 | 91.3%
| T3 | 0% | 5,918,026 |
| {28 (letrozole 2.5 MG Oral Tablet [Femara]) / 42 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 400] letrozole | 4,626 | 91.3%
| T4 | 99.3% | 209 |
| {28 (letrozole 2.5 MG Oral Tablet [Femara]) / 63 (ribociclib 200 MG Oral Tablet [Kisqali]) } Pack [Kisqali Femara Co-Pack 600] letrozole | 4,626 | 91.3%
| T4 | 99.3% | 209 |
| 4 ML bumetanide 0.25 MG/ML Injection bumetanide | 4,626 | 91.3%
| T3 | 0.8% | - |
| sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet [Vosevi] sofosbuvir | 4,620 | 91.2%
| T4 | 99.7% | 18 |
| hydrochlorothiazide 25 MG / metoprolol tartrate 100 MG Oral Tablet hydrochlorothiazide | 4,618 | 91.1%
| T2 | 0% | 4,902,174 |
| {21 (drospirenone 3 MG / ethinyl estradiol 0.03 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack drospirenone | 4,615 | 91.1%
| T2 | 0% | - |
| {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack [Vestura] drospirenone | 4,614 | 91.1%
| T2 | 0% | 406 |
| hydrochlorothiazide 50 MG / metoprolol tartrate 100 MG Oral Tablet hydrochlorothiazide | 4,612 | 91%
| T2 | 0% | 4,902,174 |
| 1 ML guselkumab 100 MG/ML Prefilled Syringe [Tremfya] guselkumab | 4,612 | 91%
| T4 | 99.3% | 8,945 |
| 1 ML guselkumab 100 MG/ML Auto-Injector [Tremfya] guselkumab | 4,612 | 91%
| T4 | 99.3% | 8,945 |
| 2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya] guselkumab | 4,612 | 91%
| T4 | 99.3% | 8,945 |
| {2 (2 ML guselkumab 100 MG/ML Auto-Injector [Tremfya]) } Pack [Tremfya Induction Pack for Crohn's Disease] guselkumab | 4,612 | 91%
| T4 | 99.3% | 8,945 |
| 2 ML guselkumab 100 MG/ML Prefilled Syringe [Tremfya] guselkumab | 4,612 | 91%
| T4 | 99.3% | 8,945 |
| {7 (desogestrel 0.1 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.125 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (desogestrel 0.15 MG / ethinyl estradiol 0.025 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Velivet 28 Day] desogestrel | 4,612 | 91%
| T2 | 0% | - |
| {24 (drospirenone 3 MG / ethinyl estradiol 0.02 MG Oral Tablet) / 4 (inert ingredients 1 MG Oral Tablet) } Pack [Jasmiel 28 Day] drospirenone | 4,606 | 90.9%
| T2 | 0% | - |
| cefprozil 25 MG/ML Oral Suspension cefprozil | 4,605 | 90.9%
| T2 | 0% | 22,839 |
| cefprozil 50 MG/ML Oral Suspension cefprozil | 4,605 | 90.9%
| T2 | 0% | 22,839 |
| amlodipine 5 MG / olmesartan medoxomil 20 MG Oral Tablet amlodipine | 4,597 | 90.7%
| T2 | 0% | 11,575,402 |
| amlodipine 10 MG / olmesartan medoxomil 20 MG Oral Tablet amlodipine | 4,597 | 90.7%
| T2 | 0% | 11,575,402 |
| amlodipine 5 MG / olmesartan medoxomil 40 MG Oral Tablet amlodipine | 4,597 | 90.7%
| T2 | 0% | 11,575,402 |
| amlodipine 10 MG / olmesartan medoxomil 40 MG Oral Tablet amlodipine | 4,597 | 90.7%
| T2 | 0% | 11,575,402 |
| 168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [Xulane] ethinyl estradiol | 4,593 | 90.6%
| T2 | 0% | 1,329 |
| 1 ML benralizumab 30 MG/ML Auto-Injector [Fasenra] benralizumab | 4,591 | 90.6%
| T4 | 100% | 2,747 |
| C1 esterase inhibitor (human) 2000 UNT Injection [Haegarda] C1 | 4,589 | 90.6%
| T4 | 99.3% | 191 |
| C1 esterase inhibitor (human) 3000 UNT Injection [Haegarda] C1 | 4,589 | 90.6%
| T4 | 99.3% | 191 |
| linagliptin 5 MG Oral Tablet [Tradjenta] linagliptin | 4,588 | 90.5%
| T3 | 0.3% | 286,808 |
| {7 (ethinyl estradiol 0.025 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Lo- Estarylla 28 Day] ethinyl estradiol | 4,588 | 90.5%
| T2 | 0% | - |
| 1 ML evolocumab 140 MG/ML Prefilled Syringe [Repatha] evolocumab | 4,587 | 90.5%
| T3 | 79.9% | - |
| {7 (ethinyl estradiol 0.025 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.025 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack ethinyl estradiol | 4,573 | 90.3%
| T2 | 0% | - |
| alanine 5.4 MG/ML / arginine 12 MG/ML / aspartate 3.2 MG/ML / cysteine 0.24 MG/ML / glutamate 5 MG/ML / glycine 3.6 MG/ML / histidine 4.8 MG/ML / isoleucine 8.2 MG/ML / leucine 1.4 MG/ML / lysine 1.2 MG/ML / methionine 3.4 MG/ML / phenylalanine 4.8 MG/ML / proline 6.8 MG/ML / serine 3.8 MG/ML / sodium acetate 0.097 MEQ/ML / sodium chloride 0.003 MEQ/ML / sodium metabisulfite 0.5 MG/ML / taurine 0.25 MG/ML / threonine 4.2 MG/ML / tryptophan 2 MG/ML / tyrosine 2.84 MG/ML / valine 7.8 MG/ML Injectable Solution [Trophamine 10 %] alanine | 4,572 | 90.2%
| T3 | 98.1% | - |
| dexmethylphenidate hydrochloride 2.5 MG Oral Tablet dexmethylphenidate hydrochloride | 4,569 | 90.2%
| T2 | 38.9% | 9,197 |
| dexmethylphenidate hydrochloride 5 MG Oral Tablet dexmethylphenidate hydrochloride | 4,569 | 90.2%
| T2 | 38.9% | 9,197 |
| dexmethylphenidate hydrochloride 10 MG Oral Tablet dexmethylphenidate hydrochloride | 4,569 | 90.2%
| T2 | 38.9% | 9,197 |
| ganciclovir 0.0015 MG/MG Ophthalmic Gel [Zirgan] ganciclovir | 4,566 | 90.1%
| T3 | 0% | 11,222 |
| cobicistat 150 MG Oral Tablet [Tybost] cobicistat | 4,563 | 90.1%
| T3 | 0% | 149 |
| 24 HR clarithromycin 500 MG Extended Release Oral Tablet clarithromycin | 4,563 | 90.1%
| T3 | 0% | - |
| estrogens, conjugated (USP) 0.625 MG/ML Vaginal Cream [Premarin] estrogens, | 4,560 | 90%
| T3 | 0% | 241,518 |
| travoprost 0.04 MG/ML Ophthalmic Solution travoprost | 4,558 | 90%
| T3 | 0.4% | 123,672 |
| {84 (ethinyl estradiol 0.03 MG / levonorgestrel 0.15 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Iclevia 91 Day] ethinyl estradiol | 4,558 | 90%
| T2 | 0% | - |
| 1.5 ML insulin glargine 300 UNT/ML Pen Injector [Toujeo] insulin glargine | 4,554 | 89.9%
| T3 | 0% | - |
| 3 ML insulin glargine 300 UNT/ML Pen Injector [Toujeo] insulin glargine | 4,554 | 89.9%
| T3 | 0% | - |
| methadone hydrochloride 1 MG/ML Oral Solution methadone hydrochloride | 4,550 | 89.8%
| T2 | 43.4% | 68,081 |
| erythromycin 333 MG Delayed Release Oral Tablet erythromycin | 4,550 | 89.8%
| T3 | 0% | 1,861 |
| erythromycin 500 MG Delayed Release Oral Tablet erythromycin | 4,542 | 89.6%
| T3 | 0% | 1,861 |
| 1000 ML glucose 25 MG/ML / sodium chloride 4.5 MG/ML Injection glucose | 4,536 | 89.5%
| T3 | 0.8% | - |
| latanoprost 0.05 MG/ML / netarsudil 0.2 MG/ML Ophthalmic Solution [Rocklatan] latanoprost | 4,535 | 89.5%
| T3 | 0.7% | 2,403,493 |
| {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Mili 28 Day] ethinyl estradiol | 4,535 | 89.5%
| T2 | 0% | - |
| candesartan cilexetil 16 MG / hydrochlorothiazide 12.5 MG Oral Tablet candesartan cilexetil | 4,530 | 89.4%
| T3 | 0% | 109,771 |
| candesartan cilexetil 32 MG / hydrochlorothiazide 12.5 MG Oral Tablet candesartan cilexetil | 4,530 | 89.4%
| T3 | 0% | 109,771 |
| candesartan cilexetil 32 MG / hydrochlorothiazide 25 MG Oral Tablet candesartan cilexetil | 4,530 | 89.4%
| T3 | 0% | 109,771 |
| piroxicam 10 MG Oral Capsule piroxicam | 4,530 | 89.4%
| T2 | 0% | 17,658 |
| piroxicam 20 MG Oral Capsule piroxicam | 4,530 | 89.4%
| T2 | 0% | 17,658 |
| {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [VyLibra 28 Day] ethinyl estradiol | 4,530 | 89.4%
| T2 | 0% | - |
| penicillin G sodium 100000 UNT/ML Injectable Solution penicillin G sodium | 4,525 | 89.3%
| T3 | 10% | 53 |
| levothyroxine sodium 0.025 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| levothyroxine sodium 0.05 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| levothyroxine sodium 0.075 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| levothyroxine sodium 0.088 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| levothyroxine sodium 0.1 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| levothyroxine sodium 0.112 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| levothyroxine sodium 0.125 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| levothyroxine sodium 0.137 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| levothyroxine sodium 0.15 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| levothyroxine sodium 0.175 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| levothyroxine sodium 0.2 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| levothyroxine sodium 0.3 MG Oral Tablet [Unithroid] levothyroxine sodium | 4,521 | 89.2%
| T2 | 0% | 8,687,969 |
| {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-VyLibra 28 Day] ethinyl estradiol | 4,519 | 89.2%
| T2 | 0% | - |
| 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela] | 4,505 | 88.9%
| T2 | 0% | - |
| 60 ACTUAT fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela] | 4,505 | 88.9%
| T2 | 0% | - |
| 60 ACTUAT fluticasone propionate 0.5 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela] | 4,505 | 88.9%
| T2 | 0% | - |
| rimantadine hydrochloride 100 MG Oral Tablet rimantadine hydrochloride | 4,504 | 88.9%
| T3 | 0% | 230 |
| lamotrigine 150 MG Oral Tablet [Subvenite] lamotrigine | 4,501 | 88.8%
| T1 | 0% | 611,083 |
| lamotrigine 25 MG Oral Tablet [Subvenite] lamotrigine | 4,501 | 88.8%
| T1 | 0% | 611,083 |
| lamotrigine 100 MG Oral Tablet [Subvenite] lamotrigine | 4,501 | 88.8%
| T1 | 0% | 611,083 |
| lamotrigine 200 MG Oral Tablet [Subvenite] lamotrigine | 4,501 | 88.8%
| T1 | 0% | 611,083 |
| deutetrabenazine 6 MG Oral Tablet [Austedo] deutetrabenazine | 4,495 | 88.7%
| T4 | 99.7% | 18,283 |
| deutetrabenazine 9 MG Oral Tablet [Austedo] deutetrabenazine | 4,495 | 88.7%
| T4 | 99.7% | 18,283 |
| deutetrabenazine 12 MG Oral Tablet [Austedo] deutetrabenazine | 4,495 | 88.7%
| T4 | 99.7% | 18,283 |
| cyclophosphamide 50 MG Oral Tablet cyclophosphamide | 4,495 | 88.7%
| T3 | 100% | 1,621 |
| trospium chloride 20 MG Oral Tablet trospium chloride | 4,494 | 88.7%
| T2 | 0.7% | 114,171 |
| 8 HR methylphenidate hydrochloride 10 MG Extended Release Oral Tablet methylphenidate hydrochloride | 4,494 | 88.7%
| T3 | 40.9% | - |
| {21 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Nylia 1/35 28 Day] ethinyl estradiol | 4,492 | 88.7%
| T2 | 0% | - |
| ampicillin 2000 MG Injection ampicillin | 4,489 | 88.6%
| T3 | 11.6% | 3,864 |
| {7 (ethinyl estradiol 0.035 MG / norethindrone 0.5 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 0.75 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norethindrone 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Nylia 7/7/7 28 Day] ethinyl estradiol | 4,484 | 88.5%
| T2 | 0% | - |
| 2.4 ML aripiprazole 300 MG/ML Prefilled Syringe [Abilify] aripiprazole | 4,481 | 88.4%
| T4 | 2.4% | 1,736 |
| 3.2 ML aripiprazole 300 MG/ML Prefilled Syringe [Abilify] aripiprazole | 4,481 | 88.4%
| T4 | 2.4% | 1,736 |
| mesalamine 1000 MG Rectal Suppository mesalamine | 4,477 | 88.4%
| T3 | 0% | 95,185 |
| hydrocortisone 0.01 MG/MG Topical Ointment hydrocortisone | 4,474 | 88.3%
| T2 | 0% | 1,257,661 |
| isotretinoin 10 MG Oral Capsule [Accutane] isotretinoin | 4,471 | 88.2%
| T3 | 45.9% | 2,097 |
| {21 (ethinyl estradiol 0.05 MG / ethynodiol diacetate 1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Valtya 1/50 28 Day] ethinyl estradiol | 4,471 | 88.2%
| T2 | 0% | - |
| Pulmonary Hypertension tadalafil 20 MG Oral Tablet Pulmonary Hypertension tadalafil | 4,470 | 88.2%
| T3 | 100% | - |